Drug archive
Adalimumab (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Rheumatoid arthritis
Description
Adalimumab (ADD-ah-lim-u-mab) is used to decreased signs, symptoms, and progression of moderately to severely active rheumatoid arthritis. It is intended for use in patients who have not responded well to other Disease Modifying Antirheumatic Drugs (DMARDS). Adalimumab can be used in combination with methotrexate or other DMARD's.
This medicine is available only with your doctor's prescription, in the following dosage forms:
- Injection (U.S.)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Adalimumab
Generic name product may be available in the U.S.
† Not commercially available in Canada.